Arvinas ARVN
NASDAQ ARVN
$9.34 +0.03 (+0.32%)
As of: Sep 4, 2026 · 12:51 PM EDT

Arvinas (ARVN) Profit After Tax (2017 - 2026)

Arvinas (ARVN) posted quarterly Profit After Tax of -$57.6 million for Q1 2026, down 169.06% year-over-year from $83.4 million in Q1 2025, and up 14.79% quarter-over-quarter from -$67.6 million in Q4 2025.

Analysis

Arvinas (ARVN) Profit After Tax (2017 - 2026) Analysis & Trends

Arvinas' Profit After Tax history runs 10 years deep, the most recent figure standing at -$57.6 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 169.06% year-over-year to -$57.6 million; the TTM figure through Mar 2026 stood at -$221.1 million (down 488.03% YoY), while the FY2025 annual figure was -$80.6 million, up 59.48% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$57.6 million, up from -$67.6 million in the prior quarter.
  • The five-year high for Profit After Tax was $83.4 million in Q1 2025, with the low at -$138.7 million in Q4 2023.
  • The 5-year median for Profit After Tax is -$62.7 million (2022), against an average of -$55.0 million.
  • The sharpest annual moves came in 2025 and 2026: Profit After Tax jumped 220.17% in 2025, then slumped 169.06% in 2026.
  • Arvinas' Profit After Tax stood at -$62.7 million in 2022, then sank by 121.21% to -$138.7 million in 2023, then soared by 67.48% to -$45.1 million in 2024, then tumbled by 49.89% to -$67.6 million in 2025, then rose by 14.79% to -$57.6 million in 2026.
  • Business Quant data shows ARVN's Profit After Tax at -$57.6 million in Q1 2026, -$67.6 million in Q4 2025, and -$34.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 81.49 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -16.62 Mn
10 Arvinas 604.91 Mn 37.01 Mn - 169.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 169.40 Mn
Mar 31, 2026 -59.20 Mn
Dec 31, 2025 -67.40 Mn
Sep 30, 2025 -35.10 Mn
Jun 30, 2025 -61.70 Mn
Mar 31, 2025 83.40 Mn
Dec 31, 2024 -45.10 Mn
Sep 30, 2024 -49.20 Mn
Jun 30, 2024 -35.20 Mn
Mar 31, 2024 -70.70 Mn
Dec 31, 2023 -154.80 Mn
Sep 30, 2023 -64.00 Mn
Jun 30, 2023 -66.60 Mn
Mar 31, 2023 -81.90 Mn
Dec 31, 2022 -77.20 Mn
Sep 30, 2022 -69.00 Mn
Jun 30, 2022 -73.30 Mn
Mar 31, 2022 -77.50 Mn
Dec 31, 2021 -57.00 Mn
Sep 30, 2021 -46.90 Mn